XML 31 R21.htm IDEA: XBRL DOCUMENT v3.19.2
Note 12 - Stock Awards
6 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
12.
STOCK AWARDS
 
In accordance with the Company’s
2013
Incentive Plan, stock awards, including stock options and restricted stock, have been granted to certain employees and non-employee directors. Shares of common stock available for distribution to satisfy the grants
may
consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner. Stock-based compensation expense related to stock awards totaled
$0.1
million for both of the
six
-month periods ended
June 30, 2019
and
2018.
 
Stock Options
  
Stock option awards have been granted with an exercise price equal to the market price of the Company’s common stock on the date of the grant and have vesting periods ranging from
one
to
three
years, with
10
-year contractual terms. 
 
The Company recognizes the cost of services received in exchange for stock option awards based on the grant date fair value of the award, with compensation expense recognized on a straight-line basis over the award’s vesting period. The fair value of outstanding awards was determined using the Black-Scholes option pricing model based on the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock.
 
   
2019
   
2018
 
Risk-free interest rate
   
2.59
%
   
2.77
%
Expected term (in years)
   
7.5
     
7.5
 
Expected stock price volatility
   
30.9
%
   
28.3
%
Dividend yield
   
1.25
%
   
1.50
%
Fair value of stock option
   
3.30
     
3.51
 
 
The following table summarizes the Company's stock option activity for the periods presented.
 
   
Six Months Ended
 
   
June 30, 2019
   
June 30, 2018
 
   
Number of
Shares
   
Average
Exercise
Price
   
Number of
Shares
   
Average
Exercise
Price
 
Options:
                               
Outstanding, beginning of period
   
377,950
   
$
9.80
     
318,000
   
$
9.43
 
Granted
   
66,150
     
10.01
     
62,150
     
11.71
 
Exercised
   
     
     
     
 
Expired
   
     
     
     
 
Forfeited
   
16,819
     
11.39
     
1,450
     
11.05
 
Options outstanding, end of period
   
427,281
   
$
9.77
     
378,700
   
$
9.80
 
Options exercisable, end of period
   
309,682
   
$
9.20
     
249,300
   
$
8.71
 
 
The aggregate intrinsic value of stock options outstanding (calculated as the amount by which the market value of underlying stock exceeds the exercise price of the option) was approximately
$0.3
million and
$0.9
million as of
June 30, 2019
and 
2018,
respectively.
 
Restricted Stock
 
During the
first
six
months of
2019
and
2018,
respectively,
5,520
shares and
10,520
shares of restricted stock were granted. The Company recognizes the cost of services received in exchange for restricted stock awards based on the grant date closing price of the stock, with compensation expense recognized on a straight-line basis over the award’s vesting period.